M M Hoeper

Summary

Publications

  1. ncbi Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension
    M M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    Am J Respir Crit Care Med 160:535-41. 1999
  2. ncbi A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group
    M M Hoeper
    Department of Pulmonary Medicine, Hannover Medical School, Germany
    J Am Coll Cardiol 35:176-82. 2000
  3. ncbi Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
    M M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Germany
    N Engl J Med 342:1866-70. 2000
  4. ncbi [Long-term treatment of primary pulmonary hypertension with inhaled iloprost]
    M M Hoeper
    Abteilung Pneumologie, Medizinische Hochschule Hannover
    Pneumologie 55:38-43. 2001
  5. ncbi Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension
    M M Hoeper
    Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany
    Chest 120:502-7. 2001
  6. ncbi Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
    M M Hoeper
    Hannover Medical School, Dept of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 26:858-63. 2005
  7. ncbi Experience with inhaled iloprost and bosentan in portopulmonary hypertension
    M M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, 30623 Hannover, Germany
    Eur Respir J 30:1096-102. 2007
  8. ncbi Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
    M M Hoeper
    Hannover Medical School, Dept of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 28:691-4. 2006
  9. doi [Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]
    M M Hoeper
    Klinik fur Pneumologie, Medizinische Hochschule Hannover, Hannover
    Pneumologie 65:208-18. 2011
  10. ncbi Long-term outcome with intravenous iloprost in pulmonary arterial hypertension
    M M Hoeper
    Hanover Medical School, Department of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 34:132-7. 2009

Detail Information

Publications23

  1. ncbi Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension
    M M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    Am J Respir Crit Care Med 160:535-41. 1999
    ..We conclude that thermodilution and acetylene rebreathing are useful tools for assessing cardiac output in patients with pulmonary hypertension, even in the presence of low cardiac output or severe tricuspid regurgitation...
  2. ncbi A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group
    M M Hoeper
    Department of Pulmonary Medicine, Hannover Medical School, Germany
    J Am Coll Cardiol 35:176-82. 2000
    ..We sought to compare the acute hemodynamic effects of inhaled nitric oxide (NO) and aerosolized iloprost in primary pulmonary hypertension (PPH)...
  3. ncbi Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
    M M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Germany
    N Engl J Med 342:1866-70. 2000
    ..Recently, aerosolized iloprost, a stable prostacyclin analogue, has been introduced as an alternative therapy for severe pulmonary hypertension...
  4. ncbi [Long-term treatment of primary pulmonary hypertension with inhaled iloprost]
    M M Hoeper
    Abteilung Pneumologie, Medizinische Hochschule Hannover
    Pneumologie 55:38-43. 2001
    ..Recently, administration of aerosolized iloprost, a stable prostacyclin analogue, has been introduced as an alternative therapy for severe pulmonary hypertension...
  5. ncbi Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension
    M M Hoeper
    Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany
    Chest 120:502-7. 2001
    ..Patients and methods: We compared hemodynamic findings, echocardiography, and MRI studies in 16 patients with pulmonary hypertension. Six healthy volunteers served as control subjects for the MRI studies...
  6. ncbi Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
    M M Hoeper
    Hannover Medical School, Dept of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 26:858-63. 2005
    ....
  7. ncbi Experience with inhaled iloprost and bosentan in portopulmonary hypertension
    M M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, 30623 Hannover, Germany
    Eur Respir J 30:1096-102. 2007
    ..Patients treated with bosentan had higher survival rates, but prospective controlled studies are required to confirm these findings...
  8. ncbi Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
    M M Hoeper
    Hannover Medical School, Dept of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 28:691-4. 2006
    ..Further studies involving larger sample sizes and long-term follow-up are needed to determine the efficacy of adding inhaled iloprost to bosentan in patients with idiopathic pulmonary arterial hypertension...
  9. doi [Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]
    M M Hoeper
    Klinik fur Pneumologie, Medizinische Hochschule Hannover, Hannover
    Pneumologie 65:208-18. 2011
    ..One of the working groups was dedicated to the diagnosis and treatment of PH in patients with chronic lung disease. The recommendations of this working group are summarized in the present paper...
  10. ncbi Long-term outcome with intravenous iloprost in pulmonary arterial hypertension
    M M Hoeper
    Hanover Medical School, Department of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 34:132-7. 2009
    ..In conclusion, despite initial haemodynamic and clinical improvement, overall long-term survival with i.v. iloprost therapy was limited...
  11. ncbi Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension
    M M Hoeper
    Hannover Medical School, Dept of Respiratory Medicine, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 24:1007-10. 2004
    ..The combination of bosentan and sildenafil was well tolerated by all patients. These preliminary data suggest that combining bosentan and sildenafil may be safe and effective in patients with idiopathic pulmonary arterial hypertension...
  12. ncbi Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
    M M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    Eur Respir J 22:330-4. 2003
    ..Therefore, rigorous studies should address whether combination treatment is more effective than either therapeutic intervention alone...
  13. doi Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation
    K M Olsson
    Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    Am J Transplant 10:2173-8. 2010
    ..All of them made a full recovery after transplantation, which demonstrates the feasibility of using ECMO support in nonintubated patients with cardiopulmonary failure as a bridging strategy to lung transplantation...
  14. ncbi Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
    M M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany
    Eur Respir J 29:944-50. 2007
    ..In patients with idiopathic pulmonary arterial hypertension, hypocapnia (carbon dioxide arterial tension <4.25 kPa) is an independent marker of mortality...
  15. ncbi Bosentan therapy for portopulmonary hypertension
    M M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, 30623 Hannover, Germany
    Eur Respir J 25:502-8. 2005
    ..s.L(-1). The medication was well tolerated by all patients, and there was no evidence of drug-related liver injury. In conclusion, bosentan proved to be efficacious and safe in a small number of patients with portopulmonary hypertension...
  16. ncbi Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
    M M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Germany
    Eur Respir J 20:339-43. 2002
    ..Since it was impossible to predict the individual effects of this approach, intravenous prostaglandin treatment should be considered in pulmonary arterial hypertension patients who deteriorate while receiving iloprost aerosol...
  17. doi [Dana Point: what is new in the treatment of pulmonary hypertension?]
    M M Hoeper
    Abteilung Pneumologie, Medizinische Hochschule Hannover
    Dtsch Med Wochenschr 133:S191-5. 2008
    ..A number of promising novel compounds are currently under investigation. These include sGC stimulators, tyrosine kinase inhibitors, and serotonin antagonists...
  18. ncbi Effects of inhaled salbutamol in primary pulmonary hypertension
    E Spiekerkoetter
    Dept of Respiratory Medicine, Hannover Medical School, Germany
    Eur Respir J 20:524-8. 2002
    ..5 kPa (45+/-19 mmHg) to 5.1+/-2.9 kPa (38+/-22 mmHg), respectively. Inhaled salbutamol has beneficial acute effects on pulmonary function, blood gases and haemodynamics in patients with primary pulmonary hypertension...
  19. ncbi [Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists]
    M M Hoeper
    Medizinische Hochschule Hannover, Abteilung Pneumologie, 30623 Hannover
    Dtsch Med Wochenschr 131:S308-10. 2006
    ..Almost all current guidelines list bosentan as of equal value to sildenafil or prostacyclin analogues in the first-line treatment of patients in NYHA functional class III and also, with narrower indications, of those in class IV...
  20. doi [Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]
    M M Hoeper
    Klinik fur Pneumologie, Medizinische Hochschule Hannover, Hannover
    Dtsch Med Wochenschr 135:S115-24. 2010
    ..One of the working groups was dedicated to the diagnosis and treatment of PH in patients with chronic lung disease. The recommendations of this working group are summarized in the present paper...
  21. doi Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device
    M Strueber
    Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany
    Am J Transplant 9:853-7. 2009
    ..Although all patients presented in cardiogenic shock, hemodynamic unloading of the right ventricle using the low-resistance LAD stabilized the hemodynamic situation immediately so that no pump support was subsequently required...
  22. ncbi [Diagnosis and treatment of pulmonary hypertension]
    M M Hoeper
    Abteilung Pneumologie Leiter Prof Dr med T Welte, Medizinische Hochschule Hannover, Hannover
    Pneumologie 60:428-40; quiz 441-2. 2006
  23. doi [Pulmonary hypertension - historical development, current therapy and perspectives]
    M M Hoeper
    Klinik fur Pneumologie, Medizinische Hochschule Hannover, Hannover
    Pneumologie 64:577-82. 2010
    ..Many aspects of the disease, however, remain poorly understood and a cure is still not achievable for the majority of the affected patients...